Clinical News
Colon Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading
Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (April 22, 2013)Results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test confirm that Recurrence Score® (RS) results improve the ability to differentiate high recurrence risk disease from low recurrence risk disease, beyond... Continue Reading
Combo Treatment Effective in Elderly Patients with Metastatic Colorectal Cancer (March 6, 2013)Combination therapy with Avastin® (bevacizumab) and Xeloda® (capecitabine) may be an optimal first-line treatment for treatment-naïve older patients with metastatic colorectal cancer, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading
Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab),... Continue Reading
Oncotype DX in Colon Cancer May Reduce Medical Costs and Improve Patient Wellbeing (February 20, 2013)The results of two studies evaluating Oncotype DX were presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco and the data indicated that the colon cancer test may reduce medical costs, improve patient wellbeing, and change treatment... Continue Reading
Cancer Deaths on the Decline (February 11, 2013)Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading
Patients with Advanced Cancer May Have Inaccurate Expectations of Chemotherapy (November 7, 2012)Patients with advanced, incurable cancer may have the inaccurate belief that chemotherapy can cure their cancer, according to the results of a study published in the New England Journal of Medicine—and such misconceptions could compromise their ability... Continue Reading
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Universal Tumor Testing to Identify Lynch Syndrome (October 30, 2012)Universal tumor MMR testing among patients with colorectal cancer may have a greater sensitivity for identifying Lynch syndrome than other screening strategies, according to the results of a study published in the Journal of the American Medical Association. Lynch... Continue Reading
B Vitamins Do Not Appear to Affect Colorectal Cancer Risk (October 22, 2012)A combination supplement of folic acid, vitamin B6 and vitamin B12 did not statistically significantly increase or decrease the risk of colorectal cancer in older women, according to the results of a study published in the Journal of the National Cancer... Continue Reading
Latest Colon Cancer News By Stage
Adjuvant (I-III, A-C) Colon Cancer
Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (April 22, 2013)
Results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test confirm that Recurrence Score® (RS) results improve the ability to differentiate high recurrence risk disease from low recurrence risk disease, beyond... Continue Reading
Oncotype DX in Colon Cancer May Reduce Medical Costs and Improve Patient Wellbeing (February 20, 2013)The results of two studies evaluating Oncotype DX were presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco and the data indicated that the colon cancer test may reduce medical costs, improve patient wellbeing, and change treatment... Continue Reading
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Oncotype DX Predicts Risk of Colon Cancer Recurrence (October 2, 2012)Among patients with Stage II or Stage III colon cancer, the Oncotype DX colon cancer test provides information about risk of cancer recurrence and overall survival, and may help guide treatment decisions. These results were presented at the European Society... Continue Reading
Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal of Clinical Oncology. Colorectal cancer is the second... Continue Reading
More Adjuvant (I-III, A-C) Colon CancerScreening/Prevention Colon Cancer
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Universal Tumor Testing to Identify Lynch Syndrome (October 30, 2012)Universal tumor MMR testing among patients with colorectal cancer may have a greater sensitivity for identifying Lynch syndrome than other screening strategies, according to the results of a study published in the Journal of the American Medical Association. Lynch... Continue Reading
B Vitamins Do Not Appear to Affect Colorectal Cancer Risk (October 22, 2012)A combination supplement of folic acid, vitamin B6 and vitamin B12 did not statistically significantly increase or decrease the risk of colorectal cancer in older women, according to the results of a study published in the Journal of the National Cancer... Continue Reading
New Colonoscopy Surveillance Guidelines (October 10, 2012)The U.S. Multi-Society Task Force on Colorectal Cancer has released a consensus update regarding colonoscopy surveillance—and the guidelines indicate that average-risk patients who have a clean colonoscopy can wait 10 years between exams. Colorectal... Continue Reading
Colonoscopy Related Factors Associated with Increased Risk of Cancer (August 31, 2012)Incomplete polyp removal and failure to have a follow-up colonoscopy within five years after the detection of the first polyp are more strongly associated with an increased risk of developing colorectal cancer than the characteristics of the polyp, according... Continue Reading
More Screening/Prevention Colon CancerStage IV (D)/Relapsed Colon Cancer
Combo Treatment Effective in Elderly Patients with Metastatic Colorectal Cancer (March 6, 2013)
Combination therapy with Avastin® (bevacizumab) and Xeloda® (capecitabine) may be an optimal first-line treatment for treatment-naïve older patients with metastatic colorectal cancer, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading
Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab),... Continue Reading
Patients with Advanced Cancer May Have Inaccurate Expectations of Chemotherapy (November 7, 2012)Patients with advanced, incurable cancer may have the inaccurate belief that chemotherapy can cure their cancer, according to the results of a study published in the New England Journal of Medicine—and such misconceptions could compromise their ability... Continue Reading
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Zaltrap Improves Survival in Metastatic Colorectal Cancer (October 16, 2012)The addition of Zaltrap® (ziv-aflibercept) to the FOLFIRI chemotherapy regimen improved overall survival in patients with metastatic colorectal cancer who were previously treated with Eloxatin® (oxaliplatin), according to the results of a phase III... Continue Reading
More Stage IV (D)/Relapsed Colon Cancer